The global Urinary Drainage Bags market gathered revenue around USD 2.0 Billion in 2020 and market is set to grow USD 4.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 6.0% during the prediction period 2021 to 2027.
Growth Factors:
The market key factors responsible for the increasing demand for urinary drainage bags as they are prone to urinary infections. Aging leads to certain changes in the lower urinary system. It includes reduced bladder capacity & feeling of fullness, decreased pelvic floor muscle resistance, reduced rate of detrusor muscle contraction, and elevated residual urine volume. Moreover, the geriatric population also faces bladder control issues, such as leakage or urinary incontinence or retention, and Chronic Kidney Disease (CKD).
The increasing geriatric population, favorable reimbursement policies, and rising prevalence of urological diseases are the key factors driving the market. There has been a constant rise in the prevalence of urologic disorders, such as urinary retention, cystitis, benign prostatic hyperplasia, Urinary Incontinence (UI), and kidney stones, which lead to bladder dysfunction. A report published by the National Center for Biotechnology Information (NCBI) in 2020 states that the prevalence of acute urinary retention is more common in men than in women and around 10.00% of men in the age group 70 to 80 years is more likely to develop acute urinary retention.
Therefore, such instances indicate that the demand for urinary drainage bags may increase, thereby propelling the market growth over the forecast period. The COVID-19 pandemic has restricted access to medical services, which has led to inadequate medical facilities for patients with various conditions. Older patients with multiple comorbidities are at a higher risk of acquiring COVID-19 due to low immunity. Older people majorly prefer using urinary drainage bags during hospital admissions due to several advantages. Therefore, a surge in hospital admission rate due to rising cases of COVID-19 is anticipated to propel the product demand to offer efficient patient care across hospital settings. Thus, the market is expected to witness significant and continuous growth post-pandemic.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Urinary Drainage Bags market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Urinary Drainage Bags market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 4.1 Billion by 2027 |
Growth Rate | CAGR of 6.0% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | Product, usage, capacity, end-use And Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | ConvaTec, Inc.; Cardinal Health; Teleflex,Inc.; Coloplast; BD; McKesson Medical Surgical, Inc.; Amsino International, Inc.; Flexicare Medical Ltd.; Medline Industries, Inc.; Manfred Sauer GmbH. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Urinary Drainage Bags market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
North America dominated the global market in 2020 with a revenue share of over 40% and is expected to witness a growth rate of 4.9% over the forecast period. The regional market is mainly driven by the rising incidence of targeted diseases, such as UI, bladder obstruction, urinary retention, Benign Prostate Hyperplasia (BPH), and bladder cancer. For instance, according to the American Academy of Family Physicians (AAFP), more than 250,000 patients with BPH undergo surgical procedures every year. As per the Canadian Cancer Society, in 2020, around 12,200 people were diagnosed with bladder cancer, and 2,600 people died due to bladder cancer. Thus, an increasing number of BPH-related surgical procedures and rising cases of bladder cancer are driving the market in North America.
Asia Pacific is anticipated to be the fastest-growing regional market during the forecast period. The increasing prevalence of BPH, spinal cord injury, and UTI is driving the regional market. UTI is one of the most prevalent infectious diseases in this region. It is associated with significant morbidity and mortality rates, particularly in hospitals, and puts a substantial financial burden on the community. Thus, rising risks of UTI, particularly in women with increasing age, parity, obesity, vaginal deliveries, surgery, constipation, and chronic respiratory problems, such as cough, are driving the market in Asia Pacific.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Urinary Drainage Bags Market include: ConvaTec, Inc.; Cardinal Health; Teleflex,Inc.; Coloplast; BD; McKesson Medical Surgical, Inc.; Amsino International, Inc.; Flexicare Medical Ltd.; Medline Industries, Inc.; Manfred Sauer GmbH
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Urinary Drainage Bags market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Urinary Drainage Bags market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Urinary Drainage Bags markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Urinary Drainage Bags market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Urinary Drainage Bags Market, By Product
7.1. Urinary Drainage Bags Market, By Product, 2021-2027
7.1.1. Large Bags
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Leg Bags
7.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Urinary Drainage Bags Market, By Usage
8.1. Urinary Drainage Bags Market, By Usage, 2021-2027
8.1.1. Reusable
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Disposable
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Urinary Drainage Bags Market, By Capacity
9.1. Urinary Drainage Bags Market, By Capacity, 2021-2027
9.1.1. 0-500 ml
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. 500-1000 ml
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. 1000-2000 ml
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Urinary Drainage Bags Market, By End-use
10.1. Urinary Drainage Bags Market, By End-use, 2021-2027
10.1.1. Hospital
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Clinics
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Urinary Drainage Bags Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.2. Market Revenue and Forecast, By Usage (2016-2027)
11.1.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.1.4. Market Revenue and Forecast, By End-use (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, By Usage (2016-2027)
11.1.5.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.1.5.4. Market Revenue and Forecast, By End-use (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, By Usage (2016-2027)
11.1.6.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.1.6.4. Market Revenue and Forecast, By End-use (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.2. Market Revenue and Forecast, By Usage (2016-2027)
11.2.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.2.4. Market Revenue and Forecast, By End-use (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, By Usage (2016-2027)
11.2.5.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.2.5.4. Market Revenue and Forecast, By End-use (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Product(2016-2027)
11.2.6.2. Market Revenue and Forecast, By Usage (2016-2027)
11.2.6.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.2.6.4. Market Revenue and Forecast, By End-use (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, By Usage (2016-2027)
11.2.7.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.2.7.4. Market Revenue and Forecast, By End-use (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, By Usage (2016-2027)
11.2.8.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.2.8.4. Market Revenue and Forecast, By End-use (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.2. Market Revenue and Forecast, By Usage (2016-2027)
11.3.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.3.4. Market Revenue and Forecast, By End-use (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, By Usage (2016-2027)
11.3.5.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.3.5.4. Market Revenue and Forecast, By End-use (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, By Usage (2016-2027)
11.3.6.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.3.6.4. Market Revenue and Forecast, By End-use (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, By Usage (2016-2027)
11.3.7.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.3.7.4. Market Revenue and Forecast, By End-use (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, By Usage (2016-2027)
11.3.8.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.3.8.4. Market Revenue and Forecast, By End-use (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.2. Market Revenue and Forecast, By Usage (2016-2027)
11.4.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.4.4. Market Revenue and Forecast, By End-use (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, By Usage (2016-2027)
11.4.5.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.4.5.4. Market Revenue and Forecast, By End-use (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, By Usage (2016-2027)
11.4.6.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.4.6.4. Market Revenue and Forecast, By End-use (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, By Usage (2016-2027)
11.4.7.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.4.7.4. Market Revenue and Forecast, By End-use (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, By Usage (2016-2027)
11.4.8.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.4.8.4. Market Revenue and Forecast, By End-use (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.2. Market Revenue and Forecast, By Usage (2016-2027)
11.5.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.5.4. Market Revenue and Forecast, By End-use (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, By Usage (2016-2027)
11.5.5.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.5.5.4. Market Revenue and Forecast, By End-use (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, By Usage (2016-2027)
11.5.6.3. Market Revenue and Forecast, By Capacity (2016-2027)
11.5.6.4. Market Revenue and Forecast, By End-use (2016-2027)
Chapter 12. Company Profiles
12.1. ConvaTec, Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cardinal Health
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Teleflex,Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Coloplast; BD
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. McKesson Medical Surgical, Inc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Amsino International, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Flexicare Medical Ltd
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Medline Industries, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Manfred Sauer GmbH
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms